Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'adrenoceptor antagonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 371 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Arnold, EP
      Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand

      BJU INTERNATIONAL
    2. Morgan, NG; Chan, SLF
      Imidazoline binding sites in the endocrine pancreas: Can they fulfil theirpotential as targets for the development of new insulin secretagogues?

      CURRENT PHARMACEUTICAL DESIGN
    3. Gomez-Ambrosi, J; Fruhbeck, G; Aguado, M; Milagro, FI; Margareto, J; Martinez, AJ
      Divergent effects of an alpha(2)-adrenergic antagonist on lipolysis and thermogenesis: Interactions with a beta(3)-adrenergic agonist in rats

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    4. Sharif, NA; Xu, SX; Crider, JY; McLaughlin, M; Davis, TL
      Levobetaxolol (Betaxon(TM)) and other beta-adrenergic antagonists: Preclinical pharmacology, IOP-lowering activity and sites of action in human eyes

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    5. Kulkarni, PS; DeSantis, L
      Vasorelaxant effects of racemic betaxolol and its R- and S-isomers on bovine retinal vessels

      JOURNAL OF GLAUCOMA
    6. Melena, J; Stanton, D; Osborne, NN
      Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    7. Sorbera, LA; Silvestre, J; Castaner, J
      KMD-3213 - Treatment of BPH alpha(1)-adrenoceptor antagonist

      DRUGS OF THE FUTURE
    8. Yoshiyama, M; De Groat, WC
      Role of spinal alpha(1)-adrenoceptor subtypes in the bladder reflex in anesthetized rats

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    9. Abouazra, HA; Sharif, SI
      Hyperglycaemia: A morphine-like effect produced by naloxone

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    10. Kwon, YB; Kang, MS; Han, HJ; Beitz, AJ; Lee, JH
      Visceral antinociception produced by bee venom stimulation of the Zhongwanacupuncture point in mice: role of alpha(2) adrenoceptors

      NEUROSCIENCE LETTERS
    11. Amadesi, S; Varani, K; Spisani, L; Daniele, C; Turini, A; Agnello, G; Zamboni, P; Borea, PA; Geppetti, P
      Comparison of Prazosin,Terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues

      PROSTATE
    12. Goepel, M; Dinh, L; Mitchell, A; Schafers, RF; Rubben, H; Michel, MC
      Do saw palmetto extracts block human alpha(1)-adrenoceptor subtypes in vivo?

      PROSTATE
    13. Demyttenaere, K; Huygens, R; Van Buggenhout, R
      Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    14. Yonezawa, A; Ando, R; Watanabe, C; Furuta, S; Kutsuwa, M; Sakurada, S; Kimura, Y
      alpha(2)-Adrenoceptor antagonists: effects on ejaculation, penile erectionand pelvic thrusting behavior in dogs

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    15. Michel, MC; Flannery, MT; Narayan, P
      Worldwide experience with alfuzosin and tamsulosin

      UROLOGY
    16. Puurunen, K; Jolkkonen, J; Sirvio, J; Haapalinna, A; Sivenius, J
      An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats

      NEUROPHARMACOLOGY
    17. Eltze, M; Boer, R; Michel, MC; Hein, P; Testa, R; Ulrich, WR; Kolassa, N; Sanders, KH
      In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha(1A)- vs. alpha(1B)- and alpha(1D)-adrenoceptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    18. Letienne, R; Vie, B; Puech, A; Vieu, S; Le Grand, B; John, GW
      Evidence that ranolazine behaves as a weak beta(1)- and beta(2)-adrenoceptor antagonist in the rat cardiovascular system

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    19. Oliveira, PJ; Rolo, AP; Sardao, VA; Coxito, PM; Palmeira, CM; Moreno, AJM
      Carvedilol in heart mitochondria - Protonophore or opener of the mitochondrial K-ATP channels?

      LIFE SCIENCES
    20. Jarajapu, YPR; Johnston, F; Berry, C; Renwick, A; McGrath, JC; MacDonald, A; Hillier, C
      Functional characterization of alpha(1)-adrenoceptor subtypes in human subcutaneous resistance arteries

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    21. Yamada, S; Okura, T; Kimura, R
      In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    22. Bolognesi, ML; Marucci, G; Angeli, P; Buccioni, M; Minarini, A; Rosini, M; Tumiatti, V; Melchiorre, C
      Analogues of prazosin that bear a benextramine-related polyamine backbone exhibit different antagonism toward alpha-adrenoreceptor subtypes

      JOURNAL OF MEDICINAL CHEMISTRY
    23. Luchowska, E; Luchowski, P; Wielosz, M; Kleinrok, Z; Urbanska, EM
      beta-adrenoceptor blockade enhances the anticonvulsant effect of glutamatereceptor antagonists against maximal electroshock

      EUROPEAN JOURNAL OF PHARMACOLOGY
    24. Bundkirchen, A; Brixius, K; Bolck, B; Mehlhorn, U; Bloch, W; Schwinger, RHG
      Nebivolol, carvedilol and metoprolol do not influence cardiac Ca2+ sensitivity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Hirai, T; Tsuru, H; Tanimitsu, N; Yajin, K; Sasa, M
      Effect of JTH-601, a putative alpha(1L)-adrenoceptor antagonist, on guineapig nasal mucosa vasculature

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Noda, K; Oka, M; Ma, FH; Kitazawa, S; Ukai, Y; Toda, N
      Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance

      EUROPEAN JOURNAL OF PHARMACOLOGY
    27. Eltze, M; Konig, H; Ullrich, B; Grebe, T
      Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Oliveira, PJ; Coxito, PM; Rolo, AP; Santos, DL; Palmeira, CM; Moreno, AJM
      Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Horio, T; Ito, S; Aoyama, M; Takeda, Y; Suzumura, H; Nakata, K; Yamada, Y; Suzuki, S; Fukutomi, T; Itoh, M
      Effect of carvedilol on atrioventricular conduction in the ischemic heart

      EUROPEAN JOURNAL OF PHARMACOLOGY
    30. Zarrindast, MR; Khodjastehfar, E; Oryan, S; Torkaman-Boutorabi, A
      Baclofen-impairment of memory retention in rats: possible interaction withadrenoceptor mechanism(s)

      EUROPEAN JOURNAL OF PHARMACOLOGY
    31. Chan, SLF; Mourtada, M; Morgan, NG
      Characterization of a K-ATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan

      DIABETES
    32. Miyazawa, Y; Blum, RA; Schentag, JJ; Kamimura, H; Matsushima, H; Swarz, H; Ito, Y
      Pharmacokinetics and safety of tamsulosin in subjects with normal and impaired renal or hepatic function

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    33. Karle, CA; Kreye, VAW; Thomas, D; Rockl, K; Kathofer, S; Zhang, W; Kiehn, J
      Antiarrhythmic drug carvedilol inhibits HERG potassium channels

      CARDIOVASCULAR RESEARCH
    34. Bruban, V; Feldman, J; Greney, H; Dontenwill, M; Schann, S; Jarry, C; Payard, M; Boutin, J; Scalbert, E; Pfeiffer, B; Renard, P; Vanhoutte, P; Bousquet, P
      Respective contributions of alpha-adrenergic and non-adrenergic mechanismsin the hypotensive effect of imidazoline-like drugs

      BRITISH JOURNAL OF PHARMACOLOGY
    35. Holden, JE; Naleway, E
      Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors

      BRAIN RESEARCH
    36. Oettl, K; Greilberger, J; Zangger, K; Haslinger, E; Reibnegger, G; Jurgens, G
      Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity

      BIOCHEMICAL PHARMACOLOGY
    37. Santos, DJSL; Moreno, AJM
      Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228

      BIOCHEMICAL PHARMACOLOGY
    38. Jayachandran, M; Hayashi, T; Sumi, D; Thakur, NK; Kano, H; Ignarro, LJ; Iguchi, A
      Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor - The role of a beta-blocker with NO-releasing action

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    39. Michel, MC; Schafers, RF; Goepel, M
      alpha-Blockers and lower urinary tract function: more than smooth muscle relaxation?

      BJU INTERNATIONAL
    40. Schwinn, DA; Michelotti, GA
      alpha(1)-Adrenergic receptors in the lower urinary tract and vascular bed:potential role for the alpha(1d) subtype in filling symptoms and effects of ageing on vascular expression

      BJU INTERNATIONAL
    41. Kirby, R; Andersson, KE; Lepor, H; Steers, WD
      alpha(1)-adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms

      PROSTATE CANCER AND PROSTATIC DISEASES
    42. Lee, M
      Tamsulosin for the treatment of benign prostatic hypertrophy

      ANNALS OF PHARMACOTHERAPY
    43. Giraldi, A; Wyllie, M; Wagner, G
      Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue

      INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
    44. Bancroft, J
      Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385)

      INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
    45. Silke, B; Hanratty, CG; Veres, SM; Riddell, JG
      beta-adrenoceptor modulation and heart rate variability - The value of scatterplot measures of compactness

      CARDIOVASCULAR DRUGS AND THERAPY
    46. Curtis, SP; Eardley, I; Boyce, M; Larson, P; Haesen, R; Gottesdiener, K; Gertz, BJ
      Single dose methodology to assess the influence of an alpha(1)-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    47. Wu, BN; Shen, KP; Lin, RJ; Huang, YC; Chiang, LC; Lo, YC; Lin, CY; Chen, IJ
      Lipid solubility of vasodilatory vanilloid-type beta-blockers on the functional and binding activities of beta-adrenoceptor subtypes

      GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM
    48. Clifford, GM; Farmer, RDT
      Medical therapy for benign prostatic hyperplasia: A review of the literature

      EUROPEAN UROLOGY
    49. De Mey, C
      alpha(1)-Blocker therapy for lower urinary tract symptoms suggestive of benign prostatic obstruction: What are the relevant differences in randomisedcontrolled trials?

      EUROPEAN UROLOGY
    50. Muller, FU; Neumann, J; Schmitz, W
      Transcriptional regulation by cAMP in the heart

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    51. Farsang, C; Garcia-Puig, J; Niegowska, J; Baiz, AQ; Vrijens, F; Bortman, G
      The efficacy and tolerability of losartan versus atenolol in patients withisolated systolic hypertension

      JOURNAL OF HYPERTENSION
    52. Mustafa, MR; Achike, FI
      Dicentrine is preferentially antagonistic to rat aortic than splenic alpha(1)-adrenoceptor stimulation

      ACTA PHARMACOLOGICA SINICA
    53. Strappaghetti, G; Barbaro, R; Marucci, G
      Synthesis and alpha(1)-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyi}-3(2H)-pyridazinone

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    54. Ohta, Y; Watanabe, K; Nakazawa, M; Yamamoto, T; Ma, ML; Fuse, K; Ito, M; Hirono, S; Tanabe, N; Hanawa, H; Kato, K; Kodama, M; Aizawa, Y
      Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    55. Lysko, PG; Webb, CL; Gu, JL; Ohlstein, EH; Ruffolo, RR; Yue, TL
      A comparison of carvedilol and metoprolol antioxidant activities in vitro

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    56. Kurz, T; Richardt, D; Gorge, B; Hartmann, F; Tolg, R; Katus, HA; Richardt, G
      Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    57. Intengan, HD; Schiffrin, EL
      Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    58. Yeh, JL; Liou, SF; Liang, JC; Huang, YC; Chiang, LC; Wu, JR; Lin, YT; Chen, IJ
      Vanidipinedilol: A vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    59. Bancroft, J; Janssen, E
      The dual control model of male sexual response: a theoretical approach to centrally mediated erectile dysfunction

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    60. Bock, MG; Patane, MA
      Toward the development of alpha(1a) adrenergic receptor antagonists

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    61. Takahashi, M; Taniguchi, T; Kanamaru, H; Okada, K; Muramatsu, I
      Pharmacological characterization of [H-3]-JTH-601, a novel alpha(1)-adrenoceptor antagonist - Binding to recombinant human alpha(1)-adrenoceptors andhuman prostates

      LIFE SCIENCES
    62. Kumar, KV; Shifow, AA; Naidu, MUR; Ratnakar, KS
      Carvedilol: A beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats

      LIFE SCIENCES
    63. Moriyama, N; Kurooka, Y; Nasu, K; Akiyama, K; Takeuchi, T; Nishimatsu, H; Murata, S; Murayama, T; Tsujimoto, G; Kawabe, K
      Distribution of alpha(1)-adrenoceptor subtype mRNA and identification of subtype responsible for renovascular contraction in human renal artery

      LIFE SCIENCES
    64. Murata, S; Taniguchi, T; Takahashi, M; Okada, K; Akiyama, K; Muramatsu, I
      Tissue selectivity of KMD-3213, an alpha(1)-adrenoceptor antagonist, in human prostate and vasculature

      JOURNAL OF UROLOGY
    65. Suzuki, Y; Moriyama, N; Okaya, Y; Kanada, A; Nishimatsu, H; Kawabe, K; Aisaka, K
      Distribution of alpha(1L)-adrenoceptors in canine prostate: Characterization by quantitative autoradiography

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    66. Abreu, RMV; Santos, DJSL; Moreno, AJM
      Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    67. Qiao, XY; Norota, I; Endoh, M
      Pharmacological characteristics of inhibitory action of the selective alpha(1)-antagonist JTH-601 on the positive inotropic effect mediated by alpha(1)-adrenoceptors in isolated rabbit papillary muscle

      JAPANESE JOURNAL OF PHARMACOLOGY
    68. Chang, RSL; Chen, TB; O'Malley, SS; Pettibone, DJ; DiSalvo, J; Francis, B; Bock, MG; Freidinger, R; Nagarathnam, D; Miao, SW; Shen, QR; Lagu, B; Dhar, TGM; Tyagarajan, S; Marzabadi, MR; Wong, WC; Gluchowski, C; Forray, C
      In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha(1A)-adrenoceptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    69. Gao, F; Chen, J; Lopez, BL; Christopher, TA; Gu, JL; Lysko, P; Ruffolo, RR; Ohlstein, EH; Ma, XL; Yue, TL
      Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model

      EUROPEAN JOURNAL OF PHARMACOLOGY
    70. Jolkkonen, J; Puurunen, K; Rantakomi, S; Harkonen, A; Haapalinna, A; Sivenius, J
      Behavioral effects of the alpha-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    71. Harada, K; Kawaguchi, A; Ohmori, M; Fujimura, A
      Antagonistic activity of tamsulosin against human vascular alpha(1)-adrenergic receptors

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    72. Mizuno, A; Miya, M; Kamei, T; Shibata, M; Tatsuoka, T; Nakanishi, K; Takiguchi, C; Hidaka, T; Yamaki, A; Inomata, N
      Studies on antihypertensive agents with antithrombotic activity. 2. Syntheses and pharmacological evaluation of pyrrolo [2,3-c]azepine derivatives

      CHEMICAL & PHARMACEUTICAL BULLETIN
    73. Cargnoni, A; Ceconi, C; Bernocchi, P; Boraso, A; Parrinello, G; Curello, S; Ferrari, R
      Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability

      CARDIOVASCULAR RESEARCH
    74. Dudley, AJ; Bleasby, K; Brown, CDA
      The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK1 cell monolayers

      BRITISH JOURNAL OF PHARMACOLOGY
    75. Watanabe, K; Ohta, Y; Nakazawa, M; Higuchi, H; Hasegawa, G; Naito, M; Fuse, K; Ito, M; Hirono, S; Tanabe, N; Hanawa, H; Kato, K; Kodama, M; Aizawa, Y
      Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy

      BRITISH JOURNAL OF PHARMACOLOGY
    76. Chidlow, G; Melena, J; Osborne, NN
      Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na+ influx into cortical synaptosomes by direct interaction with Na+ channels: comparison with other beta-adrenoceptor antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    77. Yoshioka, T; Iwamoto, N; Tsukahara, F; Irie, K; Urakawa, I; Muraki, T
      Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells

      BRITISH JOURNAL OF PHARMACOLOGY
    78. Oliveira, PJ; Marques, MPM; de Carvalho, LAEB; Moreno, AJM
      Effects of carvedilol on isolated heart mitochondria: Evidence for a protonophoretic mechanism

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    79. Lowe, F
      Alpha-1-adrenoceptor blockade in the treatment of benign prostatic hyperplasia

      PROSTATE CANCER AND PROSTATIC DISEASES
    80. Ohkura, T; Yamada, S; Tohma, A; Kimura, R; Aisaka, K
      Ex vivo and in vivo alpha(1)-adrenoceptor binding characteristics of a novel alpha(1L)-adrenoceptor antagonist, JTH-601, in rat tissues

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    81. Gobert, A; Millan, MJ
      Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone andin association with 5-HT reuptake inhibitors: Comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors

      NEUROPSYCHOPHARMACOLOGY
    82. Henry, B; Fox, SH; Peggs, D; Crossman, AR; Brotchie, JM
      The alpha(2)-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primatemodel of parkinson's disease

      MOVEMENT DISORDERS
    83. Hayashi-Morimoto, R; Yoshitomi, T; Ishikawa, H; Hayashi, E; Sato, Y
      Effects of beta antagonists on mechanical properties in rabbit ciliary artery

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    84. Prosnitz, RG; Schneider, L; Manola, J; Rocha, S; Loffredo, M; Lopes, L; D'Amico, AV
      Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: Results of a pilot study

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    85. Altwein, J; Aumuller, G; Berges, R; Dreikorn, K; Eickenberg, U; Engelmann, U; Gratzke, P; Harzmann, R; Haupt, G; Hofner, K; Jonas, D; Jonas, U; Krieg, M; Muschter, R; Pientka, L; Ringert, R; Schabel, J; Schuldes, H; Schweikert, U; Semjonow, A; Senge, T; Tunn, U; Tschuschke, C; Vogel, J; Weissbach, L; Weisser, H; Wirth, M; Zwergel, T; Zumbe, J
      Guidelines of the DGU

      UROLOGE-AUSGABE A
    86. Schafers, RF; Fokuhl, B; Wasmuth, A; Schumacher, H; Taguchi, K; de Mey, C; Philipp, T; Michel, MC
      Differential vascular alpha(1)-adrenoceptor antagonism by tamsulosin and terazosin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    87. Holden, JE; Schwartz, EJ; Proudfit, HK
      Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha(1)- and alpha(2)-adrenoceptors

      NEUROSCIENCE
    88. Bjorklund, M; Sirvio, J; Sallinen, J; Scheinin, M; Kobilka, BK; Riekkinen, P
      Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns

      NEUROSCIENCE
    89. Liang, YL; Gatzka, CD; Du, XJ; Cameron, JD; Kingwell, BA; Dart, AM
      Effects of heart rate on arterial compliance in men

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    90. Schulman, CC; Cortvriend, J; Jonas, U; Lock, TMTW; Vaage, S; Speakman, MJ
      Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: Analysis of a European, multinational, multicenter, open-label study

      EUROPEAN UROLOGY
    91. Hofner, K; Claes, H; De Reijke, TM; Folkestad, B; Speakman, MJ
      Tamsulosin 0.4 mg once daily: Effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

      EUROPEAN UROLOGY
    92. Djavan, B; Marberger, M
      A meta-analysis on the efficacy and tolerability of alpha(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

      EUROPEAN UROLOGY
    93. Speakman, MJ
      Who should be treated and how? Evidence-based medicine in symptomatic BPH

      EUROPEAN UROLOGY
    94. de Mey, C
      alpha(1)-blockers for BPH: Are there differences?

      EUROPEAN UROLOGY
    95. Debruyne, FMJ; Van der Poel, HG
      Clinical experience in Europe with uroselective alpha(1)-antagonists

      EUROPEAN UROLOGY
    96. Andre, C; Couton, D; Gaston, J; Erraji, L; Renia, L; Varlet, P; Briand, P; Guillet, JG
      beta(2)-adrenergic receptor-selective agonist clenbuterol prevents Fas-induced liver apoptosis and death in mice

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    97. Fink, B; Schwemmer, M; Fink, N; Bassenge, E
      Tolerance to nitrates with enhanced radical formation suppressed by carvedilol

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    98. Dobsak, P; Courderot-Masuyer, C; Zeller, M; Vergely, C; Laubriet, A; Assem, M; Eicher, JC; Teyssier, JR; Wolf, JE; Rochette, L
      Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    99. Bancroft, J
      Central inhibition of sexual response in the male: a theoretical perspective

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    100. Huang, YT; Lin, LC; Chern, JW; Lin, HC; Hong, CY
      Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha(1) adrenoceptor antagonist administration on anesthetized portal hypertensive rats

      LIVER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 07:56:05